-
1
-
-
33645526144
-
Cancer statistics, 2006
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.
-
(2006)
CA Cancer J Clin
, vol.56
, pp. 106-130
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
2
-
-
0022657154
-
Collective review of small carcinomas of the pancreas
-
Tsuchiya R, Noda T, Harada N, et al. Collective review of small carcinomas of the pancreas. Ann Surg. 1986;203:77-81.
-
(1986)
Ann Surg
, vol.203
, pp. 77-81
-
-
Tsuchiya, R.1
Noda, T.2
Harada, N.3
-
3
-
-
0025307965
-
The clinical utility of the CA 19-9 tumor-associated antigen
-
Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol. 1990;85:350-355.
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 350-355
-
-
Steinberg, W.1
-
4
-
-
34548401651
-
Progress on molecular markers of pancreatic cancer
-
Grote T, Logsdon CD. Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol. 2007;23:508-514.
-
(2007)
Curr Opin Gastroenterol
, vol.23
, pp. 508-514
-
-
Grote, T.1
Logsdon, C.D.2
-
6
-
-
17844377326
-
Proteomic profiling of pancreatic cancer for biomarker discovery
-
Chen R, Pan S, Brentnall TA, et al. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics. 2005;4:523-533.
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 523-533
-
-
Chen, R.1
Pan, S.2
Brentnall, T.A.3
-
7
-
-
33144455240
-
Gene expression and proteomic analysis of pancreatic cancer: A recent update
-
Chen R, Pan S, Crispin DA, et al. Gene expression and proteomic analysis of pancreatic cancer: a recent update. Cancer Genomics and Proteomics. 2006;3:1-10.
-
(2006)
Cancer Genomics and Proteomics
, vol.3
, pp. 1-10
-
-
Chen, R.1
Pan, S.2
Crispin, D.A.3
-
8
-
-
65449141024
-
A compendium of potential biomarkers of pancreatic cancer
-
Harsha HC, Kandasamy K, Ranganathan P, et al. A compendium of potential biomarkers of pancreatic cancer. PLoS Med. 2009;6:e1000046.
-
(2009)
PLoS Med
, vol.6
-
-
Harsha, H.C.1
Kandasamy, K.2
Ranganathan, P.3
-
9
-
-
3242665953
-
Cancer proteomics: Serum diagnostics for tumor marker discovery
-
Rai AJ, Chan DW. Cancer proteomics: serum diagnostics for tumor marker discovery. Ann N Y Acad Sci. 2004;1022:286-294.
-
(2004)
Ann N y Acad Sci
, vol.1022
, pp. 286-294
-
-
Rai, A.J.1
Chan, D.W.2
-
10
-
-
0035908491
-
Phases of biomarker development for early detection of cancer
-
Pepe MS, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93:1054-1061.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1054-1061
-
-
Pepe, M.S.1
Etzioni, R.2
Feng, Z.3
-
11
-
-
4644237492
-
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
-
McIntosh MW, Drescher C, Karlan B, et al. Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol. 2004;95:9-15.
-
(2004)
Gynecol Oncol
, vol.95
, pp. 9-15
-
-
McIntosh, M.W.1
Drescher, C.2
Karlan, B.3
-
12
-
-
24144467362
-
Standardizing diagnostic markers to evaluate and compare their performance
-
Pepe MS, Longton G. Standardizing diagnostic markers to evaluate and compare their performance. Epidemiology. 2005;16:598-603.
-
(2005)
Epidemiology
, vol.16
, pp. 598-603
-
-
Pepe, M.S.1
Longton, G.2
-
14
-
-
49949094123
-
Systematic evaluation of candidate blood markers for detecting ovarian cancer
-
Palmer C, Duan X, Hawley S, et al. Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS ONE. 2008;3:e2633.
-
(2008)
PLoS ONE
, vol.3
-
-
Palmer, C.1
Duan, X.2
Hawley, S.3
-
16
-
-
2442635516
-
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma
-
Koopmann J, Fedarko NS, Jain A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:487-491.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 487-491
-
-
Koopmann, J.1
Fedarko, N.S.2
Jain, A.3
-
17
-
-
0141427942
-
Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer
-
Ozkan H, Kaya M, Cengiz A. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology. 2003;50:1669-1674.
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 1669-1674
-
-
Ozkan, H.1
Kaya, M.2
Cengiz, A.3
-
18
-
-
34250348228
-
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer
-
Kuhlmann KF, van Till JW, Boermeester MA, et al. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:886-891.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 886-891
-
-
Kuhlmann, K.F.1
Van Till, J.W.2
Boermeester, M.A.3
-
19
-
-
43249129586
-
Early diagnosis of pancreatic cancer: Neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
-
Moniaux N, Chakraborty S, Yalniz M, et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer. 2008;98: 1540-1547.
-
(2008)
Br J Cancer
, vol.98
, pp. 1540-1547
-
-
Moniaux, N.1
Chakraborty, S.2
Yalniz, M.3
-
20
-
-
34548462643
-
Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer
-
Chen R, Brentnall TA, Pan S, et al. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics. 2007;6:1331-1342.
-
(2007)
Mol Cell Proteomics
, vol.6
, pp. 1331-1342
-
-
Chen, R.1
Brentnall, T.A.2
Pan, S.3
-
21
-
-
25144492709
-
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
-
Kolb A, Kleeff J, Guweidhi A, et al. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther. 2005;4:740-746.
-
(2005)
Cancer Biol Ther
, vol.4
, pp. 740-746
-
-
Kolb, A.1
Kleeff, J.2
Guweidhi, A.3
-
22
-
-
0038047893
-
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer
-
Friess H, Ding J, Kleeff J, et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci. 2003;60:1180-1199.
-
(2003)
Cell Mol Life Sci
, vol.60
, pp. 1180-1199
-
-
Friess, H.1
Ding, J.2
Kleeff, J.3
-
23
-
-
23844491522
-
Syndecan-1 expression - A novel prognostic marker in pancreatic cancer
-
Juuti A, Nordling S, Lundin J, et al. Syndecan-1 expression - a novel prognostic marker in pancreatic cancer. Oncology. 2005;68: 97-106.
-
(2005)
Oncology
, vol.68
, pp. 97-106
-
-
Juuti, A.1
Nordling, S.2
Lundin, J.3
-
24
-
-
61849105469
-
Mass spectrometry based targeted protein quantification: Methods and applications
-
Pan S, Aebersold R, Chen R, et al. Mass spectrometry based targeted protein quantification: methods and applications. J Proteome Res. 2009;8:787-797.
-
(2009)
J Proteome Res
, vol.8
, pp. 787-797
-
-
Pan, S.1
Aebersold, R.2
Chen, R.3
-
25
-
-
33947668471
-
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
-
Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266-270.
-
(2007)
Eur J Surg Oncol
, vol.33
, pp. 266-270
-
-
Goonetilleke, K.S.1
Siriwardena, A.K.2
-
26
-
-
46949105194
-
TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head
-
Sandblom G, Granroth S, Rasmussen IC. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Ups J Med Sci. 2008;113:57-64.
-
(2008)
Ups J Med Sci
, vol.113
, pp. 57-64
-
-
Sandblom, G.1
Granroth, S.2
Rasmussen, I.C.3
|